4-valent inactivated split influenza vaccine(St. Petersburg Research Institute of Vaccines and Sera)(4-valent inactivated split influenza vaccine(St. Petersburg Research Institute of Vaccines and Sera))

概要

基本信息

药物类型

灭活疫苗、预防性疫苗

别名

Flu-M Quadro

靶点-

作用方式

刺激剂

作用机制

免疫刺激剂

治疗领域

感染呼吸系统疾病

在研适应症-

非在研适应症

流感病毒感染

原研机构

St. Petersburg Research Institute of Vaccines and Sera

在研机构-

非在研机构

St. Petersburg Research Institute of Vaccines and Sera

最高研发阶段无进展临床3期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

4

项与 4-valent inactivated split influenza vaccine(St. Petersburg Research Institute of Vaccines and Sera) 相关的临床试验

NCT05308212

/ Completed临床2/3期IIT

Multicenter, Double-blind, Comparative, Randomized Tolerability, Safety and Immunogenicity Trial of the FLU-M® Tetra Inactivated Vaccine in Volunteers Aged 60 Years and Above

Comparative assessment of the tolerability, safety, and immunogenicity of the FLU-M® Tetra quadrivalent inactivated split influenza vaccine and the Ultrix® vaccine in volunteers aged 60 years and above.

开始日期2021-03-04

申办/合作机构

St. Petersburg Research Institute of Vaccines and Sera

NCT05470582

/ Completed临床3期IIT

Randomized, Double-blind, Comparative, Controlled Trial of Tolerability, Safety and Immunogenicity of the Flu-M Vaccine in Children Between 6 Months and 9 Years Old

Comparative trial of tolerability, reactogenicity, safety and immunogenicity of the Flu-M vaccine as compared to the Vaxigrip® vaccine in terms of prevention of influenza in children aged 6 months to 9 years (at the time of the first vaccination).

开始日期2021-02-16

申办/合作机构

St. Petersburg Research Institute of Vaccines and Sera

NCT05312294

/ Completed临床3期IIT

Multicenter, Double-blind, Comparative, Randomized Tolerability, Safety and Immunogenicity Trial of the Flu-M® Inactivated Vaccine in Volunteers Aged 18 to 60 Years

Comparative assessment of the tolerability, safety, and immunogenicity of the Flu-M® Inactivated Split Influenza Vaccine (without preservative) and the Flu-M® vaccine (with preservative) in volunteers aged between 18 and 60

开始日期2020-12-07

申办/合作机构

St. Petersburg Research Institute of Vaccines and Sera

100 项与 4-valent inactivated split influenza vaccine(St. Petersburg Research Institute of Vaccines and Sera) 相关的临床结果

登录后查看更多信息

100 项与 4-valent inactivated split influenza vaccine(St. Petersburg Research Institute of Vaccines and Sera) 相关的转化医学

登录后查看更多信息

100 项与 4-valent inactivated split influenza vaccine(St. Petersburg Research Institute of Vaccines and Sera) 相关的专利（医药）

登录后查看更多信息

1

项与 4-valent inactivated split influenza vaccine(St. Petersburg Research Institute of Vaccines and Sera) 相关的文献（医药）

Nanoscale Advances

Analysis of cell–nanoparticle interactions and imaging of in vitro labeled cells showing barcorded endosomes using fluorescent thiol-organosilica nanoparticles surface-functionalized with polyethyleneimine

Article

作者: Nakamura, Junna ; Mochizuki, Chihiro ; Tamanoi, Fuyuhiko ; Sugino, Norihiro ; Kakefuda, Mayu ; Kato, Shigeki ; Sato, Shun ; Nakamura, Michihiro ; Kuroda, Chika ; Haruta, Tomohiro

“Endosomal barcoded cells” via the differential intraendosomal sorting of particles depending on the particle surface were prepared using simultaneous dual-particle administration and observed on seamless biomedical imaging.

100 项与 4-valent inactivated split influenza vaccine(St. Petersburg Research Institute of Vaccines and Sera) 相关的药物交易

登录后查看更多信息